Nadciśnienie płucne – postępy w diagnostyce i leczeniu

• Authors: Konopka Marcin , Braksator Wojciech
• Languages of publication: PL

Keywords

PL

nadciśnienie płucne; diagnostyka; leczenie

• Publisher: Stowarzyszenie Przyjaciół Medycyny Rodzinnej i Lekarzy Rodzinnych
• Journal: Family Medicine & Primary Care Review
• Year: 2013
• Issue: 4
• Pages: 561-566

Contributors

author

Konopka Marcin

author

Braksator Wojciech

References

• Frost AE , Badesch DB, Barst RJ , et al. The changing picture of patients with pulmonary arterial hypertension in the United States: how RE VEA L differs from historic and non-US Contemporary Registries. Chest 2011; 139: 128–137.
• Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J2009; 30: 2493–2537.
• Guazzi M, Galie N. Pulmonary hypertension in left heart disease. Eur Respir Rev 2012; 21(126): 338–346.
• Vachiery JL, Gaine S. Challenges in the diagnosis and treatment of pulmonary arterial hypertension. Eur Respir Rev 2012; 21(126):313–320.
• Humbert M, Coghlan JG, Khanna D. Early detection and management of pulmonary arterial hypertension. Eur Respir Rev 2012;21(126): 306–312.
• Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults. J Am Soc Echocardiogr 2010; 23: 685–713.
• Pepke-Zaba J. Diagnostic testing to guide the management of chronic thromboembolic pulmonary hypertension: state of the art. Eur Respir Rev 2010; 19: 55–58.
• Vachiery JL, Yerly P, Huez S. How to detect disease progression in pulmonary arterial hypertension. Eur Respir Rev 2012; 21:40–47
• Barst RJ , McGoon M, Torbicki A, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43: 40–47.
• ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111–117
• Kurzyna M, Torbicki A, Poloński L, i wsp. Zakrzepowo-zatorowe nadciśnienie płucne – nie marnujmy szansy na skuteczne leczenie operacyjne! Kardiol Pol 2011; 69(8): 875–878.
• Ghofrani HA , Hoeper MM, Halank M, et al. Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study. Eur Respir J 2010; 36: 792–799.
• Grimminger F, Weimann G, Frey R, et al. First acute hemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension. Eur Respir J 2009; 33: 785–792.
• Stibon O, Morrell WN. Pathways in pulmonary arterial hypertension: the future is here. Eur Respir Rev 2012; 21(126): 321–327.